Compound/Extract | Plant sources | Antiviral activities | Assays | Activity* | Refs. |
---|---|---|---|---|---|
Black seed oil (BSO) or habatussaudah | Nigella sativa | Murine cytomegalo virus | In vivo using a viral plaque-forming assay of BALB/c mice spleen and liver | Undetected virus at the ratio of the effector to target cells was 20:1 | [99] |
Manuka oil |  | HSV | In vitro using a plaque reduction assay on RC-37 cells (monkey kidney cells) | IC50 = 0.96 mg/mL | [318] |
Laurus nobilis oil containing β-ocimene, 1,8-cineole, α-pinene, β-pinene | Laurus nobilis | SARS-CoV (isolate FFM-1 from Germany) | In vitro using visually scoring of the virus-induced cytopathogenic effect (CPE) for 48 h post-infection on Vero cells | IC50:120 mg/mL; SI of 4.16 | [101] |
Ethyl acetate and methanol extracts of aerial parts of D. virgatus | Daucus virgatus (Poir.) Maire | Coxsackievirus B (CV-B) | In vitro using plaque reduction assay on Hep-2 cell line | IC50 ethylacetate and methanol extracts = 98.16 and 60.08 mg/mL | [319] |
Ethanol extracts | Mentha piperita Desmodium canadense Thymus vulgaris | Avian infectious bronchitis virus (IBV) | In vitro using plaque reduction assay on Vero cells | TCID = 1.83 ± 0.31–3.45 ± 0.21 log10 EC50 = 0.003–0.076 mg | [320] |
Betulinic acid | Â | SARS-CoV 3CL pro | In vitro using FRET method | IC50 10Â mM | [95] |
The fraction containing high of cannabidiol (FCBD) | Cannabis sativa strain Arbel | Interleukin: IL-6 dan IL-8 | In vitro using enzyme-link immunosorbent assay on A549 cells | IC50 of 3.45 and 3.49Â mg/mL | [311] |
Artemisinin content | Artemisia annua L. (dried leaves) | SARS-CoV-2 USA/WA1 | In vitro using cytophatic effect assay on Vero E6 cells infected by SARS-CoV-2 | IC50 of 0.01–0.14 mg | [313] |
Cryptotanshinone | Salvia miltiorrhiza | SARS-CoV PLpro | In vitro using proteolysis of the fluorogenic substrate | IC50 = 0.8 ± 0.2 μM | [321] |
Dihydrotanshinone I | Salvia miltiorrhiza | SARS-CoV Mpro | In vitro using proteolysis of the fluorogenic substrate | IC50 = 14.4 ± 0.7 μM | [321] |
Pachymic acid | Dried sclerotia of Poria cocos (Schw.). Wolf | SARS-CoV-2 Mpro recombinant | In vitro using the fluorogenic substrate for inhibition assay | IC50: 18.607 μM | [312] |
Garlic essential oil containing 17 organosulfurs |  | ACE2 protein and main protease of SARS-CoV-2 | In silico using MOE 2015.10 on ACE2 protein and 6LU7 (Mpro) | ACE2: diallyl tetrasulfide and allyl disulfide − 14.06 and − 12.84 kcal/mol Mpro: Allyl disulfide and allyl trisulfide − 15.32 and − 15.02 kcal/mol | [322] |
β-farnesene α-farnesene farnesol α-bulnesene |  | SARS-CoV-2: Mpro (main protease), Nsp15/NendoU (endoribonucleoase), ADRP (ADP-ribose-1′′-phosphatase), rS (binding domain of the SARS-CoV-2 spike protein), RdRp (RNA-dependent RNA polymerase), and hACE2 (human angiotensin-converting enzyme) | In silico using Molegro Virtual Docker v. 6.0.1 on SARS-CoV-2 Mpro (5R7Z, 5R80, 5R81, 5R82, 5R83, 5R84, 6LU7, 6M03, 6Y84), Nsp15/NendoU (6VWW, 6W01, 6W02), rS (6M0J, 6M17, 6VX1, 6VW1), RdRp (6M71) | Docking Score (DS) SARS-CoV-2 Mpro = (E)-β-farnesene − 115.4 kJ/mol SARS-CoV Nsp15/NendoU = (E,E)-alpha-farnesene -107.5 kJ/mol SARS-CoV-2 ADRP = (E)-β-farnesene -116.3 kJ/mol SARS-CoV-2 RdRp = (E,E)-farnesol -89.6 kJ/mol hACE2 = alpha-bulnesene < -100 kJ/mol | [207] |
Eucalyptol (1,8-cineole) in eucalyptus oil |  | MPro/3CLpro of SARS-CoV-2 | In silico using 1-click dock and swiss dock tools | DS = − 4.2 ΔG = − 6.04 kcal/mol | [323] |
Jensenone in eucalyptus oil |  | MPro/3CLpro of SARS-CoV-2 | In silico using 1-click dock and swiss dock tools | DS = − 5.5 ΔG = − 6.03 kcal/mol | [205] |
Cuminal Carvacrol Myrtanol Pinocarveol |  | Receptor binding domain (RBD) of the S1 glycoprotein (residues 319–541) | In silico using AutoDock Vina on RBD of SARS-CoV-2 S1 subunit (6M07) | Binding affinity (kcal/mol): Cuminal − 4.9 Carvacrol − 4.9 Myrtanol − 5.3 Pinocarveol -5.0 | [324] |
Lauruside 5 | Laurus nobilis | SARS-CoV-2 | In silico using 1-Click Mcule on SARS-CoV-2 Mpro (6YB4) | Binding energy − 8.2 kcal/mol | [325] |
Tanshinone I | Â | SARS-CoV PLpro | In silico using Gold software with PLpro (6WX4) | IC50 of 8.8Â mM | [92] |
3-β-O-(α-L-rhamnopyranosyl-(1- > 2)α-L-arabinopyranosyl)olean-12-ene-28-O-(α-L-rhamnopyranosyl-(1- > 4)-β-D-glucopyranosyl-(1- > 6)-β-D-glucopyranosyl)ester |  | SARS-CoV-2 S-RBD | In silico using Autodock Vina with ligand 6LZG | IC50 of − 11 kcal/mol | [316] |
Limonin and scopadulcic acid B | Dictamus dasycarpus, and Citrus orange | SARS-CoV-2 RdRp (6M71), hACE2 (6M1D), and Spike glycoprotein (2GHV) | In silico using Autodock 4.2 | The docking score of limonin against RdRp, hACE2, and spike protein is − 9.0, − 8.9, and − 8.4. While docking score of scopadulcic acid B is − 8.6, − 8.2, and − 8.8 | [192] |
Carvacrol, anethol, cinnamyl acetate |  | SARS-CoV-2 RBD S1 subunit of S glycoprotein (6M0J) | In silico using AutoDock Vina | Binding affinities of three of them were − 5.2. kcal/mol | [326] |
Coagulin N | Withania coagulans (Stocks) Dunal | SARS-CoV-2 spike protein (6M0J) | In silico using AutoDock Vina | Binding energy: − 9.1 kcal/mol | [164] |
Glycyrrhizic acid | Glycyrrhiza glabra L. (liquorice roots) | SARS-CoV-2 TMPRSS2 (sequence NP_001128571.1) | In silico using AutoDock Vina | Binding energy: − 9.5 kcal/mol | [164] |
Glycyrrhizin | Glycyrrhiza glabra L | SARS-CoV-2 spike RBD (6M0J) | In silico using AutoDock 4.2 | Binding affinity: − 9.47 kcal/mol | [175] |
Ashwagandhanolide, withacoagin, withaferin, and withanone | Ayurveda botanical: Withania somnifera (roots) | SARS-CoV-2 Mpro (5R84) | In silico using AutoDock 4.2.6 | Docking score: − 9.9, and three other withanolide are − 8.8 | [236] |
Ashwagandhanolide, withacoagin, 27-hydroxywithanone | Ayurveda botanical: Withania somnifera (roots) | SARS-CoV-2 RBD spike glycoprotein (6M17) | In silico using AutoDock 4.2.6 | Docking score: − 10, and two others are − 7.6 | [236] |
Ashwagandhanolide, muzanzagenin | Ayurveda botanical: Withania somnifera (roots) | SARS-CoV-2 RdRp (6M71) | In silico using AutoDock 4.2.6 | Docking score: − 10.2 and − 9.3 | [236] |
Arjunic acid, theasapogenol B, euscaphic acid | Terminalia arjuna Camelia sasanqua Folium eriobortryde and Geum japonicum | SARS-CoV-2 Mpro (6LU7) | In silico using Autodock Vina | Binding affinities and inhibition constants: − 8.1 kcal/mol and 1.16 μM − 8.1 kcal/mol and 1.16 μM − 8.0 kcal/mol and 1.37 μM | [193] |
Crocin, digitoxigenin, β-eudesmol, | Crocus sativus L Nerium oleander Lauris nobilis L | SARS-CoV-2 Mpro (6LU7) | In silico using Autodock 1.5.4 | Binding energies: − 8.2, − 7.2, − 7.1 kcal/mol | [327] |
Calendulaglycoside A | Calendula officinalis L | SARS-CoV-2 Mpro (6LU7) | In silico using MOE 2019 Suite | Binding-free energy: − 72.14 ± 38.78 kJ/mol | [174] |